載入...
EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
Clear cell carcinoma and endometrioid adenocarcinoma are histologic subtypes of ovarian and uterine cancer that demonstrate unique clinical behavior but share common underlying genomic aberrations and oncogenic pathways. ARID1A mutations are more frequently identified in these tumors, in comparison...
Na minha lista:
| 發表在: | Gynecol Oncol Res Pract |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5663065/ https://ncbi.nlm.nih.gov/pubmed/29093822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40661-017-0052-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|